Introduction
Propolis is a natural bee product that is used as a safe dietary supplement in traditional medicine for its therapeutic benefits. One of the natural active components in propolis is caffeic acid phenethyl ester (CAPE), which is an ester of caffeic acid and phenethyl alcohol [1] . Numerous studies have shown that CAPE possesses multifunctional biological properties across a broad range of systems, including antibacterial, anti-inflammatory, antioxidant, antiviral, anticarcinogenic, and immunomodulatory properties [2] [3] [4] [5] [6] [7] [8] [9] . For example, CAPE exhibited inhibitory effects on the production of proinflammatory cytokines (interleukin-1β, tumor necrosis factor (TNF)-α, and monocyte chemoattractant protein-1) from lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages [10] . Song et al.
[11] also found that CAPE protected human middle ear epithelial cells against H 2 O 2 -induced inflammatory and oxidative reactions via CAPE-mediated inhibition of expression of the proinflammatory cytokine TNF-α and the proinflammatory enzyme COX-2. Furthermore, CAPE has been shown to markedly reduce mRNA expression of the inflammatory cytokines TNF-α and interferon-gamma (IFN-γ) in streptozotocin diabetic rats; it has been suggested that CAPE could prevent the development of inflammation after irradiation, which is widely used for the treatment and management of cancer [12] .
To benefit from these activities, CAPE needs to reach the target tissues at a specific concentration, which must then be maintained for a certain period of time. Therefore, since CAPE is usually administered orally as a component of propolis, it is crucial to assess its bioavailability following In this study, we synthesized a glycosylated derivative of caffeic acid phenethyl ester (CAPE) using the amylosucrase from Deinococcus geothermalis with sucrose as a substrate and examined its solubility, chemical stability, and anti-inflammatory activity. Nuclear magnetic resonance spectroscopy showed that the resulting glycosylated CAPE (G-CAPE) was the new compound caffeic acid phenethyl ester-4-O-α-D-glucopyranoside. G-CAPE was 770 times more soluble than CAPE and highly stable in Dulbecco's modified Eagle's medium and buffered solutions, as estimated by its half-life. The glycosylation of CAPE did not significantly affect its anti-inflammatory activity, which was assessed by examining lipopolysaccharide-induced nitric oxide production and using a nuclear factor erythroid 2-related factor 2 reporter assay. Furthermore, a cellular uptake experiment using high-performance liquid chromatography analysis of the cell-free extracts of RAW 264.7 cells demonstrated that G-CAPE was gradually converted to CAPE within the cells. These results demonstrate that the glycosylation of CAPE increases its bioavailability by helping to protect this vital molecule from chemical or enzymatic oxidation, indicating that G-CAPE is a promising candidate for prodrug therapy.
Keywords: Amylosucrase, anti-inflammation, bioavailability, caffeic acid phenethyl ester, glycoside, transglycosylation oral ingestion. The solubility and stability of drugs are frequently improved using the solid dispersion/nanoparticle technique [13] [14] [15] [16] [17] , chemical modification [18] , and preparation of a complex with cyclodextrins [19] . However, all of these methods have drawbacks, including compromised product purity, difficulty of preparation, and environmental pollution.
Transglycosylation has been used to improve the physicochemical properties (e.g., water solubility and oxidative stability) of various compounds using the enzymes from various bacteria as catalysts. For example, the water solubility of piceid glucosides synthesized using maltosyltransferase from Caldicellulosiruptor bescii DSM 6725 was 1.86 × 10 3 times higher than that of the original piceid [20] . Furthermore, Kometani et al. [21] synthesized glucosyl hesperidin by transglycosylation with cyclodextrin glucanotransferase from alkalophilic Bacillus, which has been shown to have an approximately 10,000 times higher solubility and similar antioxidant properties to hesperidin in vitro [22] , as well as greater biological activities [23] . Various phenolic compounds have been glycosylated using bacterial amylosucrases, such as rutin, baicalein, arbutin, (+)-catechin, and salicin, with the resulting glycosides having improved solubilities and stabilities than the original compounds [24] [25] [26] [27] [28] .
Therefore, the aim of this study was to investigate the in vitro stability and solubility of glycosylated CAPE (G-CAPE) as a potential prodrug. CAPE was glycosylated by enzymatic transglycoslyation, and the effects of glycosylation on its bioavailability and anti-inflammatory activity were then assessed.
Materials and Methods

Chemicals and Reagents
CAPE, sulforaphane, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT), and fetal bovine serum (FBS) were purchased from Sigma-Aldrich (USA). High-performance liquid chromatography (HPLC)-grade water, acetonitrile, and methanol were purchased from Burdick & Jackson (USA) for purification. All other chemicals were of reagent grade and purchased from Sigma-Aldrich. Toll-like receptor 4 (TLR4)-specific Escherichia coli LPS was purchased from Alexis Biochemical (USA). Antibodies against nuclear factor erythroid 2-related factor 2 (Nrf2) (H-300) and lamin A/C (H-110) were obtained from Santa Cruz Biotechnology (USA). Recombinant amylosucrase from Deinococcus geothermalis (DGAS) was prepared as previously described [26] .
Animal Cell Culture
Cells derived from the murine macrophage cell line RAW 264.7 (ATCC, USA) were cultured in Dulbecco's modified Eagle's medium supplemented with 10% (v/v) heat-inactivated FBS (cDMEM; Thermo, USA), 100 U/ml penicillin, and 100 μg/ml streptomycin (Gibco, USA) at 37°C under 5% CO 2 in a humidified culture chamber (Sanyo Electric Biochemical Co., Ltd, Japan). Nrf2 reporter cell lines were prepared as previously described [29] .
Synthesis of Caffeic Acid Phenethyl Ester Glucoside Using DGAS
To synthesize G-CAPE, a substrate solution containing 10 mM CAPE and 20 mM sucrose in 50 mM Tris-HCl buffer (pH 8.0) was preincubated at 30°C for 10 min. Dimethyl sulfoxide was then added (up to 20% (v/v) ) to dissolve the CAPE. Following preincubation, DGAS (1 mg/ml) was added to the reaction mixture and the enzymatic synthesis was carried out at 30°C for 12 h [26] . The transfer reaction was stopped by heating the reaction mixture in boiling water for 10 min, following which the reaction mixture was centrifuged at 3,000 ×g for 20 min to remove any insoluble substances. The supernatant fraction was then filtered with a 0.45-μm syringe filter (Satorius, Germany).
Purification of G-CAPE
The reaction products were separated using a C 1 8
-T cartridge and recycling preparative HPLC. The transglycosylation reaction mixture was filtered with a 0.45-μm syringe filter (Sartorius) and added to the Strata C 1 8 -T cartridge (200 mg/3 ml; Phenomenex, USA), which had previously been activated with methanol and water, to absorb the G-CAPE. After washing twice, the transfer products were eluted with methanol. The main transfer product was then further purified using a JAIGEL W-252/W-251 column (2 × 50 cm; Japan Analytical Industry Co., Ltd (JAI), Korea) in the recycling preparative HPLC equipped with a refractive index detector (JAI) and eluted with methanol at a flow rate of 3.0 ml/min with 30 kgf/cm 2 column pressure. The purified product was lyophilized and the purity of G-CAPE was confirmed using thinlayer chromatography (TLC).
TLC Analysis
The purified transfer product was dissolved in n-butanolethanol-water (5:3:2 (v/v/v)) and analyzed using TLC with a Whatman K5F silica gel plate (Whatman, UK). After irrigating twice, the TLC plate was dried and visualized using an ultraviolet (UV) lamp in combination with a UV viewing box (Camag, Switzerland) at 254 nm. The transfer product was also visualized by dipping it into a solution containing 0.3% (w/v) N-(1-naphthyl)-ethylenediamine and 5% (v/v) H 2 SO 4 in methanol, followed by heating at 110°C for 10 min.
UPLC Analysis
CAPE and G-CAPE in cell lysates were analyzed by ultraperformance liquid chromatography (UPLC) using a previously published method [30] with slight modification. An Acquity UPLC H-Class system (Waters, Ireland) was used, which comprised a Model bioSample Manager-FTN, a Model bioQuaternary Solvent
